Sign Out
Since there are no adequate and well-controlled studies in pregnant women, this drug should be used only if the potential benefits to the mother justify the possible risk to the fetus. It is not known if mefenamic acid or its metabolite crosses the placenta.
Trace amounts of mefenamic acid may be present in breast milk and transmitted to the nursing infant.
Continue with Google